Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NoOne

Financiado

A binary sensor with single-molecule digit to discriminate biofluids enclosing z...

A binary sensor with single-molecule digit to discriminate biofluids enclosing zero or at least one biomarker Biomarkers are measurable indicators of a particular disease state of an organism. There has been an increasing demand for diagnostic markers, enabling reliable and non-invasive screening of peripheral biofluids. It is also establ... ver más

31/03/2027

UNIBA

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

UNIVERSITA DEGLI STUDI DI BARI ALDO MORO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-03-18

ERC-2021-STG: ERC STARTING GRANTS Scope:Objectives

I+D

Cerrada hace 3 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

UNIBA

1.97M€ | Lider

Åbo Akademi University

530.57K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PTQ-10-03152 Desarrollo de plataformas multisensoras para la detección de... 60K€ Cerrado

CTQ2012-34238 PLATAFORMAS SENSORAS BASADAS EN NUEVOS BIORRECEPTORES DE AFI... 212K€ Cerrado

PID2021-123183OB-I00 PLATAFORMAS SENSORAS ELECTROQUIMICAS BASADAS EN ACIDOS NUCLE... 169K€ Cerrado

PID2021-127137OB-I00 PROTEOMICA Y MIRNOMICA DIRIGIDA PARA ABORDAR BIOMARCADORES D... 139K€ Cerrado

ALA DIAGNOSTICS MS KIT Revolutionising the diagnosis of multiple Sclerosis with the... 2M€ Cerrado

CTQ2015-63567-R SELECCION Y MODIFICACION DE APTAMEROS COMO RECEPTORES ESPECI... 90K€ Cerrado

Duración del proyecto: 60 meses Fecha Inicio: 2022-03-18
Fecha Fin: 2027-03-31

Líder del proyecto

UNIVERSITA DEGLI STUDI DI BARI ALDO MORO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Descripción del proyecto Biomarkers are measurable indicators of a particular disease state of an organism. There has been an increasing demand for diagnostic markers, enabling reliable and non-invasive screening of peripheral biofluids. It is also established that a universal screening against life-threatening diseases, such as cancer, or infectious disease outbreaks, can be accomplished only by combining genomic and protein marker-based tests. The NoOne project aims at conceiving, engineering, fabricating and validating a ground-breaking platform based on a single-molecule binary bioelectronic sensor, capable to reliably discriminate biofluid samples enclosing zero biomarkers from those containing just one. The technology can be used for ultimate binary sensing of both proteins/peptides and genomic markers to enable the reliable screening of diseases such as cancer as well as viral and bacterial infections. The NoOne binary platform is designed to be portable, cost-effective, easy to operate and with a time-to-results within one hour; hence it is the ideal candidate for point-of-care applications. The prototype will enable clinicians, phytopathologists or veterinaries, to identify the set of samples that are totally free from a protein, peptide or genomic marker as well as from a pathogen (virus or bacteria), from those enclosing at least one with a confidence level of 99%. This makes the NoOne platform the best performing ever in enabling a fast, highly reliable, cost-effective identification of the subset of biological samples belonging to the potentially diseased part of a population. This is of paramount importance for predictive screening of humans, plants or animals. NoOne will demonstrate its effectiveness in key relevant applications such as the binary detection of pancreatic cancer biomarkers, SARS-CoV-2 virus, the Xylella Fastidiosa bacterium and the assay of post translational peptides evidencing the phosphorylated forms regulating crosstalk with oncogenic signalling pathways.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores